Monuril (Fosfomycin Trometamol)

Fosfomycin trometamol penetrates bacterial cells via glycerophosphate transporters and binds irreversibly to the MurA enzyme, which catalyzes the first step of peptidoglycan synthesis. By blocking this step, the drug prevents formation of the bacterial cell wall, leading to bactericidal activity against a broad spectrum of Gram‑positive and Gram‑negative organisms commonly responsible for urinary tract infections.

The dosing regimen for Monuril is determined by the prescribing clinician based on the patient’s age, renal function, and the specific infection being treated. Typically, a single oral dose is administered for uncomplicated urinary tract infection, but the exact amount and any adjustments must be specified by the healthcare provider. Patients should follow the prescriber’s instructions precisely.

Safety data for fosfomycin trometamol in pregnancy are limited, and the drug is generally classified as use‑only when the potential benefit outweighs any possible risk to the fetus. It is excreted in breast milk, so caution is advised for nursing mothers. Physicians should evaluate the clinical situation and discuss potential risks and alternatives with the patient before prescribing.

To request Monuril, visit the product page on gnhindia.com, enter the desired quantity, and submit the inquiry form. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifying trade or institutional credentials before providing a formal quotation. The sales team will respond with pricing, availability, shipping details—including any required temperature controls—and assistance with import documentation.

Compared with other oral agents such as nitrofurantoin or trimethoprim‑sulfamethoxazole, fosfomycin offers the convenience of a single‑dose regimen and retains activity against many multidrug‑resistant uropathogens. However, its spectrum is narrower for certain organisms, and resistance can develop with repeated use. Clinicians consider local susceptibility patterns, patient tolerance, and dosing convenience when selecting the most appropriate urinary antiseptic.

Monuril should be stored at ambient temperature, preferably below 25 °C, in its original blister pack or container. The product must be kept away from moisture, direct sunlight, and excessive heat to maintain stability. Do not store in bathrooms or near kitchen appliances, and keep out of reach of children.

Monuril is taken orally as a single dose, usually with a full glass of water. The tablet should be swallowed whole and not chewed or crushed. Patients are advised to take the medication on an empty stomach, at least 30 minutes before or after meals, to optimize absorption. Specific instructions may vary, so patients should follow the prescribing clinician’s guidance.

The most serious adverse reactions to fosfomycin trometamol include severe allergic responses such as anaphylaxis, life‑threatening skin conditions like Stevens‑Johnson syndrome or toxic epidermal necrolysis, and Clostridioides difficile‑associated colitis. Renal or hepatic impairment may also occur, particularly in patients with pre‑existing organ dysfunction. Prompt medical attention is required if any signs of these reactions develop.

Monuril is contraindicated in individuals with a known hypersensitivity to fosfomycin, its salts, or any of the tablet excipients. Patients with severe renal impairment (e.g., creatinine clearance below 10 mL/min) should avoid the drug unless dose adjustment is explicitly directed by a physician. It should also be used with caution in pregnant or breastfeeding women, and in patients taking medications that may interact significantly, such as certain anticoagulants or antacids.